{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:50:27Z","timestamp":1790351427030,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yexmp.2015.04.007","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T14:12:16Z","timestamp":1429971136000},"page":"16-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A thirty-five nucleotides BCR-ABL1 insertion mutation of controversial significance confers resistance to imatinib in a patient with chronic myeloid leukemia (CML)"],"prefix":"10.1016","volume":"99","author":[{"given":"Silvia","family":"Marc\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurdes","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cabez\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuensanta","family":"Mill\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evarist","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2015.04.007_bb0005","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.yexmp.2015.04.007_bb0010","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1056\/NEJMc061882","article-title":"Dasatinib in chronic myelogenous leukemia","volume":"355","author":"Chu","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2015.04.007_bb0015","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia \u2014 a Europe Against Cancer Program","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.yexmp.2015.04.007_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2353\/jmoldx.2008.070128","article-title":"An intron-derived insertion\/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy","volume":"10","author":"Laudadio","year":"2008","journal-title":"J. Mol. Diagn."},{"issue":"12","key":"10.1016\/j.yexmp.2015.04.007_bb0025","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1535-7163.MCT-08-0482","article-title":"BCR-ABL alternative splicing as a common mechanism for imatinib resistance: evidence from molecular dynamics simulations","volume":"7","author":"Lee","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.yexmp.2015.04.007_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000210060","article-title":"BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors","volume":"121","author":"Ma","year":"2009","journal-title":"Acta Haematol."},{"issue":"18","key":"10.1016\/j.yexmp.2015.04.007_bb0035","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1182\/blood-2010-02-269233","article-title":"Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS","volume":"115","author":"Mahadeo","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.yexmp.2015.04.007_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.medcli.2012.10.028","article-title":"Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitors","volume":"141","author":"Marc\u00e9","year":"2013","journal-title":"Med. Clin."},{"issue":"1","key":"10.1016\/j.yexmp.2015.04.007_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00277-011-1215-2","article-title":"Imatinib resistance and blast transformation of chronic myeloid leukemia associated with a novel tri-nucleotide insertion mutation of BCR-ABL kinase domain at position K294","volume":"91","author":"Nadarajan","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.yexmp.2015.04.007_bb0050","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1182\/blood-2011-05-349191","article-title":"The BCR-ABL35INS insertion\/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia","volume":"118","author":"O'Hare","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.yexmp.2015.04.007_bb0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12185-011-0766-2","article-title":"A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis","volume":"93","author":"Sakai","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.yexmp.2015.04.007_bb0060","article-title":"ISCN 2013. An international system for human cytogenetic nomenclature (2013). Recommendations for international standing committee on human cytogenetic nomenclature","author":"Shaffer","year":"2013","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.yexmp.2015.04.007_bb0065","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1038\/bcj.2013.3","article-title":"Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation","volume":"3","author":"Sigl","year":"2013","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.yexmp.2015.04.007_bb0070","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","article-title":"Organizaci\u00f3n Mundial de la Salud and Asociaci\u00f3n Internacional de Investigaci\u00f3n sobre el Cancer","author":"Swerdlow","year":"2008"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480015000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T13:39:13Z","timestamp":1617457153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480015000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0014480015000945"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.04.007","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A thirty-five nucleotides BCR-ABL1 insertion mutation of controversial significance confers resistance to imatinib in a patient with chronic myeloid leukemia (CML)","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2015.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}